ALISON MULLINS: Open Payments
NPI 1518526169 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 30 payments from 12 companies in 2025. Trend: 2023 $554 · 2024 $677 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $110 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Alkermes, Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: Azstarys, INVEGA SUSTENNA, REXULTI, VRAYLAR, INGREZZA, LYBALVI, AUSTEDO XR, Auvelity.
Industry payments across KY — which companies pay providers there.
